
Dr. Greco Angela
Doctor
Contacts
- Mail: angela.greco@istitutotumori.mi.it
- Tel: 0223903222
Specialty / Department
- Biologist
Degree in Biological Sciences, specialization in Applied Genetics.
After graduation, I carried out research on an ongoing basis first at the New York University School of Medicine (1984-1989), and subsequently at the National Cancer Institute of Milan (1989-present).
Since 1989, I have been involved in the characterization of the molecular mechanisms involved in the development of solid tumors, with particular interest in thyroid tumors. In this field, I have contributed with important studies: isolation and characterization of TRK oncogenes, functional characterization of RET oncogenes; identification of the molecular characteristics that favour oncogenic rearrangements; functional role of differentially expressed genes in thyroid tumors; role of senescence in thyroid tumors; identification of non-oncogenes necessary for the survival of thyroid tumor cells.
I have also contributed to the identification of the molecular mechanisms involved in GIST and dermatofibrosarcoma protuberans.
AIRC-IG2021-ID26107-SENESCENCE IN THYROID CANCER PROGRESSION AND THERAPY RESISTANCE: PRECLINICAL STUDIES AND THERAPEUTIC IMPLICATIONS
RF-2019-12369158 - Dissect the effects of COPZ1 targeting: a promising strategy for different solid tumors
- Mail: angela.greco@istitutotumori.mi.it
- Tel: 0223903222
Biologia Integrata dei Tumori rari
Biologia Integrata dei Tumori rari
ANALIZZARE GLI EFFETTI DEL TARGETING DI COPZ1: UNA STRATEGIA PROMETTENTE PER DIVERSI TUMORI SOLIDI
ANALIZZARE GLI EFFETTI DEL TARGETING DI COPZ1: UNA STRATEGIA PROMETTENTE PER DIVERSI TUMORI SOLIDI
SENESCENZA NELLA PROGRESSIONE E NELLA RESISTENZA ALLE TERAPIE DEL CANCRO DELLA TIROIDE: STUDI PRECLINICI E IMPLICAZIONI TERAPEUTICHE
SENESCENZA NELLA PROGRESSIONE E NELLA RESISTENZA ALLE TERAPIE DEL CANCRO DELLA TIROIDE: STUDI PRECLINICI E IMPLICAZIONI TERAPEUTICHE
Last update: 27/08/2025